There may be evidence that these agents lessen neuronal activity while in the nigrostriatal pathway and should act by inhibition of dopaminergic synapses (Roth, 1976). Experiments in rats With all the [14C]deoxyglucose system have demonstrated that γ-butyrolactone creates profound dose-dependent reductions of glucose utilization all through the brain (Wolfson et https://derekn284kif8.bloggazza.com/profile